Skip to content

CorMedix CRMD Net Operating Loss Carryforwards

Net Operating Loss Carryforwards at other companies

Merck & Co. logo
Merck & Co.MRK
$1.2B+31.5%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:OperatingLossCarryforwards.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's net operating loss carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's net operating loss carryforwards?
CorMedix (CRMD) reported net operating loss carryforwards of $91.5 in Q4 2025.
How has CorMedix's net operating loss carryforwards changed year-over-year?
CorMedix's net operating loss carryforwards decreased by 100.0% year-over-year, from $113.6M to $91.5.
What is the long-term trend for CorMedix's net operating loss carryforwards?
Over 5 years (2020 to 2025), CorMedix's net operating loss carryforwards has grown at a -87.5% compound annual growth rate (CAGR), from $2.96M to $91.5.
What does net operating loss carryforwards mean?
These are tax assets representing losses that can be used to reduce taxable income in future periods. They provide a potential future tax shield, improving cash flow by lowering future tax payments. Investors monitor these to estimate the duration and magnitude of potential tax savings.